Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neostigmine and Atropine for PDPH Prevention
NCT06493838Phase 4Not yet recruiting
- Sponsor
- Minia University
- Start
- Jul 2024
- Primary completion
- Jan 2025
- Modality
- Classical Binding Small Molecules
01
Overview
A Phase 4 trial of neostigmine, atropine in post-dural puncture headache (PDPH), sponsored by Minia University. Planned start Jul 2024; status: not yet recruiting.
02
Drugs
neostigmineatropine
03
Conditions
post-dural puncture headache (PDPH)
Beyond the preview
Go deeper on NCT06493838.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06493838.